亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Risk Factors Associated with Arteriovenous Fistula Failure after First Radiologic Intervention

动静脉瘘 医学 干预(咨询) 放射科 护理部
作者
Alexandra Romann,Monica Beaulieu,Pascal Rhéaume,Jason Clement,Ravindar S. Sidhu,Mercedeh Kiaii
出处
期刊:Journal of Vascular Access [SAGE]
卷期号:17 (2): 167-174 被引量:30
标识
DOI:10.5301/jva.5000459
摘要

Purpose Improving arteriovenous fistula (AVF) patency is an integral part of the care of hemodialysis patients, often requiring procedures such as percutaneous transluminal angioplasty (PTA). However, these interventions may fail to reduce AVF dysfunction and failure. The purpose of this study was to determine predictive factors for subsequent AVF failure post-PTA. Methods Data from 155 consecutive AVFs in 155 patients at a single institution who had undergone a first PTA and had at least 1 year of follow-up data were analyzed. Using survival analysis, we assessed primary and secondary patency, and identified predictive factors taking into account competing risks. Results Of the 155 patients, 52% required multiple subsequent PTAs; 32% of the AVFs were not in use prior to the first PTA. At first PTA, 83% had outflow vein stenosis (OVS), 26% had multiple stenoses and 43% of stenoses were longer than 2 cm. During follow-up, 1-, 2-, 3-year postintervention primary patency was 41%, 32%, 32% and secondary patency was 80%, 71% and 68%. AVFs with stenoses greater than 2 cm or OVS were at higher risk of requiring multiple PTAs (p = 0.04, 0.006). Factors associated with requiring a second PTA included stenosis greater than 2 cm (hazard ratio (HR) = 1.8, 95% confidence interval (CI) = 1.2-2.9), OVS (HR = 2.5, 95% CI = 1.1-5.4) and primary renal diagnosis of diabetes or renal vascular diseases (HR = 1.8, 95% CI = 1.1-2.9); after adjustments for competing risks, OVS and stenosis length remained associated with requiring subsequent PTAs. Conclusions The location and size of the AVF stenosis at first PTA appear to be consistent factors associated with worse postintervention primary patency.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
10秒前
凉水发布了新的文献求助10
15秒前
隐形曼青应助科研通管家采纳,获得10
16秒前
19秒前
ding应助ldy539采纳,获得10
19秒前
小二郎应助Lululu采纳,获得10
22秒前
26秒前
波波应助凉水采纳,获得10
28秒前
ldy539发布了新的文献求助10
32秒前
凉水完成签到,获得积分10
37秒前
liuliu完成签到,获得积分20
1分钟前
Chenyol完成签到 ,获得积分10
1分钟前
忧伤的尔白完成签到,获得积分10
1分钟前
Frecklesss发布了新的文献求助10
1分钟前
1分钟前
香蕉觅云应助ceeray23采纳,获得20
2分钟前
Frecklesss完成签到,获得积分10
2分钟前
3分钟前
3分钟前
欢呼沅发布了新的文献求助10
3分钟前
充电宝应助欢呼沅采纳,获得10
3分钟前
赘婿应助曲幻梅采纳,获得10
3分钟前
Hello应助Founder采纳,获得30
3分钟前
3分钟前
3分钟前
3分钟前
ph完成签到 ,获得积分10
3分钟前
苏震坤发布了新的文献求助10
4分钟前
4分钟前
乐正亦寒完成签到 ,获得积分10
4分钟前
4分钟前
fabius0351完成签到 ,获得积分10
4分钟前
Lululu发布了新的文献求助10
4分钟前
渡边曜应助健康的雁风采纳,获得10
4分钟前
4分钟前
4分钟前
4分钟前
5分钟前
5分钟前
曲幻梅发布了新的文献求助10
5分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Kinesiophobia : a new view of chronic pain behavior 5000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
Weaponeering, Fourth Edition – Two Volume SET 1000
First commercial application of ELCRES™ HTV150A film in Nichicon capacitors for AC-DC inverters: SABIC at PCIM Europe 1000
Handbook of pharmaceutical excipients, Ninth edition 800
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5996819
求助须知:如何正确求助?哪些是违规求助? 7470671
关于积分的说明 16081061
捐赠科研通 5139838
什么是DOI,文献DOI怎么找? 2756061
邀请新用户注册赠送积分活动 1730374
关于科研通互助平台的介绍 1629686